New vaccines and treatments are linked to a dramatic decline in RSV hospitalizations for babies, according to a new study from the US Centers for Disease Control and Prevention (CDC).
This past winter was the first RSV season with widespread availability of a vaccine given during pregnancy and a monoclonal antibody treatment given in the first eight months of life to prevent RSV (respiratory syncytial virus).
